Doripenem
Records for this ingredient, by country (identity only).
ATC J01DH04 · 6 markets · 8 records
JP 3 records · 2 shown of 2
- 250 mg per mL / per unit basis not statedinjectionフィニバックスキット点滴静注用0.25gフィニバックス点滴静注用0.5g
- 500 mg per mL / per unit basis not statedinjectionフィニバックス点滴静注用0.5g
GB 1 records · 1 shown of 1
- 500 mg per mL / per unit basis not statedinjectionDoribax 500mg powder for solution for infusion vials
TW 1 records · 1 shown of 1
- 250 mg per mL / per unit basis not statedinjectionFinibax® for Injection 0.25g伏霸®注射劑 0.25公克
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | GB | TW | JP |
|---|---|---|---|
| 250 mgRecorded as: 0.25 g per mL / per unit basis not stated cannot compare injection | Finibax® for Injection 0.25g 伏霸®注射劑 0.25公克 | フィニバックスキット点滴静注用0.25g フィニバックス点滴静注用0.5g | |
| 500 mg per mL / per unit basis not stated cannot compare injection | Doribax 500mg powder for solution for infusion vials | フィニバックス点滴静注用0.5g |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.